A significant fraction of the biopharma pipeline is held by small – and even virtual – biopharma companies. These companies often lack the all of the capabilities, expertise and/or bandwidth necessary to advance their molecules to initial clinical studies. In the absence of internal resources, small biopharma often look to contract development and manufacturing organizations...
Biologics are becoming increasingly important in terms of new drug products and sales. In this presentation we will discuss innovative approaches to expediting biosimilar development. The presentation will have a comprehensive overview, 1. Growth opportunities for Biosimilars - new trends and advancements 2. Key trends impacting commercialization. 3. Application (Oncology, Rheumatology, Inflammatory and Other Application)...
Join The World's Largest Global Biotech Partnering Experience BIO Digital is the world's largest virtual biotech partnering and education event, convening thousands of global biotech leaders and innovators. Join us in our efforts to accelerate a BIO-Revolution through global partnerships, collaboration, and thought leadership. Now more than ever, the world is counting on us to come...
Patients living with rare diseases are often persistently misdiagnosed or undiagnosed, potentially resulting in no treatment at all or treatments that are ineffective or unsafe. Due to the lack of definitive diagnostics or efficacious and safe therapies, foundations and research centers have been raising funds for re-purposing existing therapeutics or developing new drugs (typically classified...
The RARE Drug Development Symposium is a two-day interactive event in partnership with The Penn Medicine Orphan Disease Center that focuses on educating both beginners and advanced participants on the drug development process. Here, all members of the rare disease community are encouraged to explore their role in the rare disease drug development process in new and...
Biocom California invites you to a upcoming webinar where we will review the upcoming changes to Cal/OSHA’s Emergency Temporary Standards (ETS) anticipated to go into effect in June. The discussion will cover modifications to the ETS, how the ETS updates will interact with the newly relaxed CDC guidelines for fully vaccinated individuals, and the bottom-line...
This meeting is one of many screening forums organized by SoCalBio to select the best device, biotech, and digital health company candidates to make presentations during: The 23rd Annual SoCalBio Conference on October 20-22, 2021 5th SoCalBio Digital Health Conference on March 23-25, 2022
Serving Unmet Medical Needs in Veterinary Medicine Through Business Partnering and Investment WHY ATTEND The 5th Animal Health Innovation USA is the must attend networking event in North America for innovators with new solutions to support the detection, prevention or treatment of diseases in animals. Our mission is to showcase the most exciting investment opportunities...
The San Diego Biotechnology Network (SDBN) began connecting life science professionals in 2008, and expanded into the California bay area and Los Angeles in late 2019 and into virtual events in 2020. Like other communities, we have realized the power of connecting virtually. Virtual networking tools have advanced to the point where geographic boundaries are less of an obstacle...
How Investors View Valuations Wednesday, June 16, 2021, 3-4pm. Come take advantage of the opportunity to hear about how valuations for startups are negotiated. We will learn how investors see the world and the factors they take into account when placing a bet on your company.
See 9 breakthrough point-of-care innovations and learn about strategic partnership and grant opportunities that can accelerate YOUR startup. For the second straight year, The Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Disorders is pleased to present this high-energy, high-value event for life sciences startups. Join us and...
As Chief Science Officer at Impossible Foods, Dr. John York, PhD, leads a fast-growing R&D team expected to double in size in 2021. Before joining the company in January, York served as the Chair of the Department of Biochemistry and a Professor of Biochemistry at Vanderbilt University from 2012 to 2020, where his laboratory paved...
